Home>
US Stocks>
Oncology Institute/the

Oncology Institute/the share price today

(TOI)

Oncology Institute/the share price is $0.22 & ₹18.74 as on 25 Dec 2024, 2.30 'hrs' IST

$0.22

▲

0.02

(9.46%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Oncology Institute/the share price in Dollar and Rupees. Guide to invest in Oncology Institute/the from India. Also see the sentimental analysis on Indian investors investing in Oncology Institute/the. Get details on the Indian mutual funds that are investing in Oncology Institute/the. Get Analyst recommendations and forecasts along with all the Oncology Institute/the's financials.

Oncology Institute/the share price movements

Today's Low: $0.20
Today's High: $0.24
$0.22
7.59%
Downside
Day's Volatility :14.87%
Upside
7.87%
52 Weeks Low: $0.13
52 Weeks High: $2.50
$0.22
43.05%
Downside
52 Weeks Volatility :94.99%
Upside
91.2%

Oncology Institute/the Returns

Period	Oncology Institute Inc/the	Sector (Health Care)	Index (Russel 2000)
3 Months	-25.38%	-8.7%	0.0%
6 Months	-50.24%	-5.0%	0.0%
1 Year	-89.0%	3.2%	0.0%
3 Years	-97.94%	0.0%	-21.1%

Oncology Institute/the Key Statistics

in dollars & INR

Previous Close	$0.2041
Open	$0.22
Today's High	$0.2388
Today's Low	$0.2033
Market Capitalization	$15.4M
Today's Volume	$731.3K
52 Week High	$2.5
52 Week Low	$0.1253
Revenue TTM	$361.1M
EBITDA	$-57.3M
Earnings Per Share (EPS)	$-0.77
Profit Margin	-19.81%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-125.59%

How to invest in Oncology Institute/the from India?

It is very easy for Indian residents to invest directly in Oncology Institute/the from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Oncology Institute/the stock in both Indian Rupees (INR) and US Dollars (USD). Search for Oncology Institute/the or TOI on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Oncology Institute/the or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Oncology Institute/the shares which would translate to 3.873 fractional shares of Oncology Institute/the as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Oncology Institute/the, in just a few clicks!

Returns in Oncology Institute/the for Indian investors in Rupees

Investment Value

₹1,00,000

Oncology Institute/the investment value today

Current value as on today

₹13,264

Returns

₹86,736

(-86.74%)

Returns from Oncology Institute/the Stock

₹89,163 (-89.16%)

Dollar Returns

₹2,426 (+2.43%)

Indian investors sentiment towards Oncology Institute/the

19.44%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Investment in Oncology Institute/the from India has grown in the last 30 days as on Dec 26, 2024. 19.44% more purchase transactions for Oncology Institute/the in the last 30 days versus the previous period.

61%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Oncology Institute/the on INDmoney from India has grown in the last 30 days as on Dec 26, 2024. 61% more investors are searching Oncology Institute/the in the last 30 days versus the previous period.

Global Institutional Holdings in Oncology Institute/the

FMR Inc
6.29%
Deerfield Management Co
4.45%
TIFF Advisory Services Inc
3.48%
Cincinnati Insurance Co
2.69%
Vanguard Group Inc
2.36%
Kent Lake Capital LLC
2.32%

Analyst Recommendation on Oncology Institute/the

Buy

80%Buy

20%Hold

0%Sell

Based on 5 Wall street analysts offering stock ratings for Oncology Institute/the(by analysts ranked 0 to 5 stars)

Based on 5 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Oncology Institute/the

What analysts predicted

Upside of 809.09%

Current:

$0.22

Target:

$2.00

Insights on Oncology Institute/the

Price Movement
In the last 7 days, TOI stock has moved up by 20.0%
Increasing Revenue
Revenue is up for the last 15 quarters, 48.58M → 99.90M (in $), with an average increase of 5.0% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -15.47M → -16.11M (in $), with an average decrease of 4.1% per quarter
TOI vs THC (1 yr)
In the last 1 year, Tenet Healthcare Corp. has given 71.2% return, outperforming this stock by 158.5%
TOI vs THC (3 yr)
In the last 3 years, Tenet Healthcare Corp. has given 63.7% return, outperforming this stock by 161.6%
Price to Sales
ForTOI every $1 of sales, investors are willing to pay $0.0, whereas for Tenet Healthcare Corp. , the investors are paying $0.6 for every $1 of sales.

Oncology Institute/the Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$113.2M	-
Net Income	$3.9M	-
Net Profit Margin	3.49%	-

	FY19	Y/Y Change
Revenue	$155.4M	↑ 37.33%
Net Income	$-4.0M	↓ 201.86%
Net Profit Margin	-2.59%	↓ 6.08%

	FY20	Y/Y Change
Revenue	$187.5M	↑ 20.66%
Net Income	$-14.3M	↑ 256.13%
Net Profit Margin	-7.64%	↓ 5.05%

	FY21	Y/Y Change
Revenue	$203.0M	↑ 8.26%
Net Income	$-10.9M	↓ 23.7%
Net Profit Margin	-5.38%	↑ 2.26%

	FY22	Y/Y Change
Revenue	$252.5M	↑ 24.37%
Net Income	$1.7M	↓ 115.16%
Net Profit Margin	0.66%	↑ 6.04%

	FY23	Y/Y Change
Revenue	$324.2M	↑ 28.42%
Net Income	$-83.1M	↓ 5113.16%
Net Profit Margin	-25.62%	↓ 26.28%

	Q2 FY23	Q/Q Change
Revenue	$80.2M	↑ 5.29%
Net Income	$-16.9M	↓ 43.67%
Net Profit Margin	-21.06%	↑ 18.31%

	Q3 FY23	Q/Q Change
Revenue	$82.0M	↑ 2.26%
Net Income	$-17.4M	↑ 3.09%
Net Profit Margin	-21.23%	↓ 0.17%

	Q4 FY23	Q/Q Change
Revenue	$85.8M	↑ 4.57%
Net Income	$-15.3M	↓ 12.08%
Net Profit Margin	-17.85%	↑ 3.38%

	Q1 FY24	Q/Q Change
Revenue	$94.7M	↑ 10.35%
Net Income	$-16.3M	↑ 6.26%
Net Profit Margin	-17.19%	↑ 0.66%

	Q2 FY24	Q/Q Change
Revenue	$98.6M	↑ 4.13%
Net Income	$-15.5M	↓ 4.87%
Net Profit Margin	-15.7%	↑ 1.49%

	Q3 FY24	Q/Q Change
Revenue	$99.9M	↑ 1.34%
Net Income	$-16.1M	↑ 4.1%
Net Profit Margin	-16.13%	↓ 0.43%

	FY18	Y/Y Change
Profit	$26.3M	-

	FY19	Y/Y Change
Profit	$29.9M	↑ 13.92%

	FY20	Y/Y Change
Profit	$36.9M	↑ 23.17%

	FY21	Y/Y Change
Profit	$40.8M	↑ 10.76%

	FY22	Y/Y Change
Profit	$52.1M	↑ 27.53%

	FY23	Y/Y Change
Profit	$59.6M	↑ 14.36%

	Q2 FY23	Q/Q Change
Profit	$15.1M	↑ 7.22%

	Q3 FY23	Q/Q Change
Profit	$16.0M	↑ 5.7%

	Q4 FY23	Q/Q Change
Profit	$12.8M	↓ 19.88%

	Q1 FY24	Q/Q Change
Profit	$10.5M	↓ 18.14%

	Q2 FY24	Q/Q Change
Profit	$13.0M	↑ 24.29%

	Q3 FY24	Q/Q Change
Profit	$14.4M	↑ 10.29%

	FY18	Y/Y Change
Operating Cash Flow	$5.6M	-
Investing Cash Flow	$2.5M	-
Financing Cash Flow	$-8.2M	-

	FY19	Y/Y Change
Operating Cash Flow	$3.6M	↓ 35.92%
Investing Cash Flow	$-1.2M	↓ 148.4%
Financing Cash Flow	$-1.8K	↓ 99.98%

	FY20	Y/Y Change
Operating Cash Flow	$508.2K	↓ 85.94%
Investing Cash Flow	$-8.8M	↑ 634.22%
Financing Cash Flow	$11.9M	↓ 655447.3%

	FY21	Y/Y Change
Operating Cash Flow	$-32.7M	↓ 6530.05%
Investing Cash Flow	$-230.0M	↑ 2500.6%
Financing Cash Flow	$154.0M	↑ 1195.51%

	FY22	Y/Y Change
Operating Cash Flow	$-61.8M	↑ 88.97%
Investing Cash Flow	$-131.6M	↓ 42.78%
Financing Cash Flow	$92.2M	↓ 40.13%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-8.7M	↓ 43.96%
Investing Cash Flow	$24.9M	↑ 0.0%
Financing Cash Flow	$-2.6M	↑ 52.19%

Oncology Institute/the Technicals Summary

Sell

Neutral

Buy

Oncology Institute/the is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Oncology Institute/the Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Oncology Institute Inc/the	47.46%	-50.24%	-89.0%	-97.94%	-97.7%
Fresenius Medical Care Ag	2.71%	18.47%	7.94%	-29.65%	-38.12%
Hca Holdings, Inc.	-7.4%	-11.26%	12.31%	20.04%	106.45%
Tenet Healthcare Corp.	-10.94%	-6.21%	69.96%	62.1%	242.97%
Universal Health Services Inc.	-12.07%	-5.4%	18.75%	40.8%	27.04%
Davita Healthcare Partners Inc.	-7.68%	9.62%	49.15%	39.48%	109.31%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Oncology Institute Inc/the	47.33	NA	NA	0.0	-1.26	-0.19	NA	0.77
Fresenius Medical Care Ag	19.38	19.38	0.47	2.06	0.06	0.03	0.03	46.43
Hca Holdings, Inc.	13.62	13.62	0.98	21.93	0.12	0.12	0.01	-8.57
Tenet Healthcare Corp.	4.11	4.11	0.6	11.1	0.6	0.07	NA	40.32
Universal Health Services Inc.	12.07	12.07	1.87	15.92	0.16	0.07	0.0	100.14
Davita Healthcare Partners Inc.	16.51	16.51	1.15	9.74	0.45	0.07	NA	4.68

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Oncology Institute Inc/the	Buy	$15.4M	-97.7%	47.33	-19.81%
Fresenius Medical Care Ag	Hold	$13.3B	-38.12%	19.38	3.43%
Hca Holdings, Inc.	Buy	$76.9B	106.45%	13.62	8.52%
Tenet Healthcare Corp.	Buy	$12.3B	242.97%	4.11	14.91%
Universal Health Services Inc.	Hold	$12.0B	27.04%	12.07	6.66%
Davita Healthcare Partners Inc.	Hold	$12.6B	109.31%	16.51	6.53%

About Oncology Institute/the

the oncology institute of hope and innovation is a premier cancer treatment center in los angeles. offering programs to help patients and families cope with the challenges that are brought on by cancer and strive to optimize their quality of life, comprehensive and realistic treatment goals are tailored to every person's unique needs and decided upon in partnership with the patients and their families. dedicated to excel in cancer prevention, diagnosis and education through our exceptional team of physicians, nurse practitioners, nurses, medical assistants and office staff, the oncology institute of hope and innovation has 8 southern california locations in the cities of downey, long beach, lynwood, montebello whittier, anaheim, la mirada and glendale. for more information please visit www.theoncologyinstitute.com.

Organization	Oncology Institute/the
Employees	800
CEO	Mr. Richard Alan Barasch
Industry	Financial

Management People of Oncology Institute/the

Name	Title
Mr. Richard Alan Barasch	Chairman of the Board
Dr. Daniel Virnich FACHE, M.B.A., M.D.	CEO & Executive Director
Dr. Yale D. Podnos F.A.C.S., M.D., M.P.H.	Chief Medical Officer
Mr. Rob Carter	Chief Financial Officer
Mr. Jeremy N. Castle M.B.A.	Chief Operations Officer
Mr. Mark Hueppelsheuser Esq.	General Counsel
Ms. Laura Szitar	Chief People Officer
Mr. Jordan McInerney	Chief Development Officer

Important FAQs about investing in Oncology Institute/the from India :

What is Oncology Institute/the share price today?

Oncology Institute/the share price today stands at $0.22, Open: $0.22 ; Previous Close: $0.20 ; High: $0.24 ; Low: $0.20 ; 52 Week High: $2.50 ; 52 Week Low: $0.13. The stock opens at $0.22, after a previous close of $0.20. The stock reached a daily high of $0.24 and a low of $0.20, with a 52-week high of $2.50 and a 52-week low of $0.13.

Can Indians buy Oncology Institute/the shares?

Yes, Indians can invest in the Oncology Institute/the (TOI) from India.

With INDmoney, you can buy Oncology Institute/the at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Oncology Institute/the at zero transaction cost.

How can I buy Oncology Institute/the shares from India?

It is very easy to buy Oncology Institute/the from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Oncology Institute/the be purchased?

Yes, you can buy fractional shares of Oncology Institute/the with INDmoney app.

What are the documents required to start investing in Oncology Institute/the stocks?

To start investing in Oncology Institute/the, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.